Trial Profile
Phase 1 SAD/MAD study of SBT-020 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs SBT 020 (Primary)
- Indications Huntington's disease
- Focus Adverse reactions
- 09 Mar 2017 New trial record